Liver Transfection Kit

Modes of administration

Systemic intravenous (i.v.) injectionDirect intratumoral (i.t.) injectionIntraperitoneal (i.p.) injection

Description

The liver is the largest internal organ and digestive organ of the human body, and an important organ for the human body to participate in processes such as digestion, excretion, detoxification, and immunity. The liver is responsible for most of the drug uptake, as well as reducing the first-pass effect of therapeutic drugs and dominating drug metabolism. Therefore, its related diseases are common clinical diseases, such as fatty liver, viral hepatitis, liver cirrhosis, liver cancer and so on. These liver diseases are a serious threat to human health. In order to help researchers explore the mechanism of these diseases and find suitable therapeutic drugs. CD BioSciences has developed a liver-targeted delivery system that targets liver cells. The system can localize the delivery molecule to the lesion site of the liver, reduce the dosage and administration frequency of the research molecule, and improve the effect. Through the liver-targeted delivery system, siRNA, DNA and other molecules can be accurately delivered to liver cells, and can enhance the solubility of poorly soluble drugs, protect drugs from degradation, produce slow and controlled release effects, reverse multidrug resistance, change Pharmacokinetic process, change in vivo biodistribution and other characteristics.

CD BioSciences manufactures and supplies the Liver In Vivo Kit for in vivo studies. Contact us to find out how the Liver In Vivo Kit can help your work.